|
Illegal peptides and proteins |
ILPEP |
January 2, 2015 |
December 31, 2018 |
Medicines and health products |
biopharmaceuticals, counterfeit, peptides, life-saving medicines, life-style drugs |
|
Dietary exposure of the Belgian population (adults and children) to pyrrolizidine alkaloids |
PASFOOD |
January 1, 2015 |
June 30, 2017 |
Organic contaminants and additives, Lifestyle and chronic diseases |
pyrrolizidine alkaloids, food exposure, LC-MS/MS |
|
Hepatitis E virus epidemiology: follow up of an emerging food-borne zoonosis in Belgium |
HEV EPI |
January 1, 2015 |
December 31, 2019 |
Viral diseases, Epidemiology of infectious diseases |
hepatitis E virus, epidemiology, surveillance, emergence, zoonosis |
|
Introduction of MALDI-TOF for species identification and drug susceptibility testing in mycobacteria |
MALDIMYCO |
January 1, 2015 |
October 31, 2018 |
Bacterial diseases, Mycology and aerobiology , Risk and health impact assessment |
MALDI-TOF, mycobacteria, drug susceptibility testing, diagnostic methods |
|
Impact of green/blue spaces on specific morbidity and cause-specific mortality in Belgium |
GRESP-HEALTH |
December 15, 2014 |
March 15, 2019 |
Risk and health impact assessment |
environment, green space, blue space, morbidity, mortality, inequity, biodiversity |
|
Preparation of an epidemiological response tool in the event of a sanitary crisis due to a chemical accident |
|
November 3, 2014 |
|
Risk and health impact assessment |
crises, chemical accident, emergency preparedness, biomonitoring |
|
Preparation of CEN Technical Specification: “Guidance on detection and identification of nano-objects in complex matrices”(WI 00352012, CEN-TC352-WG3-PG2) |
CEN project |
September 1, 2014 |
December 31, 2017 |
Trace elements and nanomaterials |
nano-objects, complex matrix, guidance document |
|
Initiative for Quality improvement and Epidemiology in multidisciplinary Diabetic Foot Clinics |
IQED-Foot |
July 1, 2014 |
|
Health services research |
Diabetes, diabetes care, diabetic foot, quality improvement, audit-feedback |
|
Development of targeted genotyping methods for improved drug resistance surveillance |
mPLEXABR |
June 1, 2014 |
|
Bacterial diseases, Transversal activities in applied genomics, Veterinary bacteriology |
antibiotic resistance, genetic determinant, multiplex identification, beta-lactamases, fluoroquinolones, enterobacteriaceae |
|
Human genomic biomarker RTqPCR array for optimised and mechanistically-based genotoxicity assessment |
GENOMARK |
May 1, 2014 |
December 31, 2018 |
Risk and health impact assessment, Transversal activities in applied genomics |
toxicogenetics, transcriptomics, DNA damage, genotoxicity tests, gene expression profiling, in vitro, 3R, alternative method |
|
OIE Laboratory Twinning project for foot-and-mouth disease diagnostic laboratory capacity building in Nigeria |
OIE Twinning FMD |
May 1, 2014 |
April 30, 2018 |
Exotic viruses and particular diseases |
foot-and-mouth disease, disease control, diagnostics, staff training, quality control, biosafety, Nigeria |
|
Protective Effect of South African Plants on Mycotoxin-Induced Mutagenicity and Toxicity |
Z.-Afrika |
April 1, 2014 |
February 28, 2018 |
Risk and health impact assessment |
Mycotoxin, mutagenicity, antimutagenicity, Vitotox test, comet assay, micronucleus test |
|
Modeling the absorption of cadmium in leaf and root crops |
FoodCad |
March 1, 2014 |
February 29, 2016 |
Trace elements and nanomaterials, Organic contaminants and additives |
cadmium, spinach, carrots, modeling, root uptake |
|
Development of a prioritisation strategy for hazard characterisation of substances migrating from printed paper and board food contact materials based on their genotoxicity |
PRIMISTRA |
February 17, 2014 |
February 14, 2018 |
Risk and health impact assessment, Organic contaminants and additives |
food contact materials, printing inks, paperboard, genotoxicity, gene mutation, in silico, in vitro, 3R |
|
Expert Support for the assessment of applications for certificates of conformity, the monitoring of technological developments and research into health effects on wireless technology |
LNE-2014-2016-2018 |
February 3, 2014 |
June 30, 2020 |
Risk and health impact assessment |
mobile phone, radiofrequency radiation, non ionising radiation, biological effects, in vitro, in vivo |
|
Antigenic drift in the surface proteins of the mumps virus and its impact on vaccine efficacy |
Bofvax |
January 1, 2014 |
December 31, 2018 |
Viral diseases |
Mumps, vaccination, virus-neutralisation test, immunity, T cell, B cell, epitopes, antigenicity |
|
A 12-years trend analysis of candidemia in Belgium: incidence, drug resistance and antifungal consumption |
CglabrataR |
January 1, 2014 |
June 30, 2018 |
Mycology and aerobiology , Healthcare-associated infections and antimicrobial resistance |
candidemia, antifungal resistance, antifungal consumption, nosocomial diseases, yeast, fungi, mycology |
|
Development of an integrated approach based on validated and standardised methods to support the implementation of the EC recommendation for a definition of nanomaterial |
NanoDefine |
November 1, 2013 |
October 31, 2017 |
Trace elements and nanomaterials |
nanomaterials, EC definition, TEM, dispersion protocols, software validation |
|
Tick-borne encephalitis virus eco-epidemiology: study of the prevalence and pathogenesis in rodents and wild animals |
TBEV Epi |
October 1, 2013 |
December 31, 2019 |
Viral diseases, Epidemiology of infectious diseases, Quality of vaccines and blood products |
tick-borne encephalitis virus, ticks, sentinel, seroprevalence, rodents |
|
Accelerated Development of Vaccine Benefit-Risk Collaboration in Europe |
ADVANCE |
October 1, 2013 |
September 30, 2018 |
Epidemiology of infectious diseases, Quality of vaccines and blood products |
vaccination, immunisation, preventive, therapeutical, pharmacovigilance, epidemiology, surveillance, risk/benefit assesment, patients |
|
Use of proteomics for the quality control of intravenous immunoglobulins |
PLPROT |
October 1, 2013 |
September 30, 2017 |
Quality of vaccines and blood products |
proteomics, quality control, immunoglobulins, plasma derivatives |
|
Belgian Bioelectromagnetics Group |
ELIA2 |
July 1, 2013 |
July 1, 2017 |
Risk and health impact assessment |
electromagnetic fields, Alzheimer’s disease, genetic effects, project coordination, BBEMG |
|
Improvement of anti-TB treatment by study of antibiotic resistance mechanisms |
TB drugs |
June 24, 2013 |
|
Bacterial diseases |
mycobacterium tuberculosis, antibiotic resistance, genetic changes, protein structure, mutants, DNA sequencing |
|
A common European approach to the regulatory testing of Manufactured Nanomaterials |
NANoREG |
March 1, 2013 |
February 28, 2017 |
Trace elements and nanomaterials |
nanomaterials, EC definition, TEM, inter laboratory comparison, SOP validation |
|
Virus-host interplay at the early stages of infection |
BELVIR |
October 1, 2012 |
September 30, 2017 |
Trace elements and nanomaterials |
myxoviruses, glycoproteins, TEM, attachment-fusion, mucus, GFP |
|
Bioavailability and transformation of arsenic from food: role of food preparation, preservation and digestion |
BIOTRAs |
February 1, 2012 |
January 31, 2015 |
Trace elements and nanomaterials |
arsenic, speciation, bioaccessibility, risk evaluation, exposure, food preparation |
|
Intradermal rabies vaccination trials in humans: towards shorter and cheaper rabies vaccination |
Intradermo |
January 1, 2011 |
December 31, 2019 |
Viral diseases |
rabies, intradermal vaccination, clinical trials |
|
National Reference Laboratory/Centre for Rabies: surveillance and diagnosis of rabies in man and animal |
NRL/NRC Rabies |
January 1, 2011 |
December 31, 2019 |
Viral diseases |
rabies, lyssavirus, bats, diagnosis, serology, surveillance |
|
Initiative for Quality Improvement and Epidemiology in Children and Adolescents with Diabetes |
IQECAD |
February 1, 2009 |
|
Health services research |
Diabetes, diabetes care, diabetic children, diabetic adolescents, young diabetic patients, quality improvement, audit-feedback |
|
Belgian neuromuscular diseases registry |
BNMDR |
January 1, 2008 |
|
Health services research |
neuromuscular diseases, register |
